ALDX - FDA says more data needed to approve Aldeyra dry eye drug (update)
2023-11-27 17:12:15 ET
More on Aldeyra Therapeutics
- Why I Am Selling Aldeyra Therapeutics: A Sour AbbVie Deal And A Lack Of Transparency
- Aldeyra:Upcoming PDUFA, Strong NDA, Long Pipeline, Decent Cash
- Eyeing Returns: Aldeyra's Shift From Lab To Market
- AbbVie enters option deal for Aldeyra dry eye disease drug
- Aldeyra Therapeutics 10% owner disposes stake worth $4.45M
For further details see:
FDA says more data needed to approve Aldeyra dry eye drug (update)